Author

H. Kim

Observed name: Hyung-Don Kim

Institutions: Asan Medical Center, University of Ulsan

Observed institutions: Asan Medical Center, University of Ulsan, Ulsan University Hospital

OpenAlex ID: A5115040953

LBA1 Multicenter phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab (KCSG HB23-04)

2024 · C. Yoo, H-D. Kim, et al. · Annals of Oncology · 8

Modeling analysis of RATIONALE-305: Impact of peritoneal metastasis (PM) representation on clinical outcomes in patients (pts) treated with tislelizumab plus chemotherapy (TIS+CT) with gastric cancer/gastroesophageal junction cancer (GC/GEJC).

2026 · Mohamad Bassam Sonbol, Sun Young Rha, et al. · Journal of Clinical Oncology · 1

156P Efficacy of ipilimumab plus nivolumab therapy in patients having hepatocellular carcinoma with main portal vein invasion (Vp4): Multicenter real-world study

2024 · J.S. Kim, B. Kang, et al. · Annals of Oncology · 1

Works count: 4

Citation count: 18

H-index: 2

I10-index: